Health

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has completed the installation of two new cyclotrons at Telix Manufacturing Solutions (TMS) in Brussels South,Belgium, facilita...

2024-12-19 17:02 2578

LG Corp. Chairman and CEO Kwang Mo Koo sends 2025 New Year Address to 270,000 global employees on December 19

* "Let's Shape LG's Future with the DNA of Challenge and Change We've had Since Day 1" * Highlighting LG's Spirit – the DNA of challenge and change since Day 1 -        "LG's Day 1 spirit of choosing what others wouldn't dare comes from our DNA of challenge and change as we serve our customer...

2024-12-19 13:00 1312

"You've Got a Friend" Charity Concert Aims to Promote Mental Wellness

HONG KONG, Dec. 19, 2024 /PRNewswire/ -- The "You've Got a Friend" charity concert, organized by the Hong Kong Mental Wellness Association, will take place from April 9 to 11, 2025, at the Rita Tong Liu Drama Theatre of the Hong Kong Academy for Performing Arts. The concert aims to raise public a...

2024-12-19 12:55 2330

Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare

SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a pioneer in Internet healthcare solutions, announced a strategic alliance with Bristol Myers Squibb ("BMS")China on December 16th. The partnership was officially formalized with the signing of a colla...

2024-12-19 12:40 1109

Caliway to Present CBL-514 Phase 2b Study Results for Subcutaneous Fat Reduction at IMCAS 2025 in Paris

* The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS, the premier global congress in aesthetic medicine. The data will be highlighted in both the 2025 focus session on advances in fat reduction therapies and further detailed in the Non-surgical B...

2024-12-19 10:47 1170

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight, a liquid bi...

2024-12-19 01:00 1934

Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical

Highlights * Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis and treatment of cancer. * The product, termed SAR-bisFAP, has shown strong tumour targeting...

2024-12-18 22:03 1453

DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data

Leading cloud-based enterprise platform for precision health data empowers biopharma companies with actionable insights to accelerate drug discovery and development     SAN ANTONIO, Dec. 18, 2024 /PRNewswire/ -- Frost & Sullivan researched the bioinformatics-based drug discovery and development ...

2024-12-18 22:00 1155

Boryung Announces Winners of the 3rd Humans In Space Challenge

Paving the Way as a Global Leader in Space Healthcare - Introducing of a new funding model to support space experiments and strengthen research in space healthcare - Hosted the final round of the Humans In Space Challenge at the 75th International Astronautical Congress SEOUL, South Korea, Dec....

2024-12-18 22:00 1422

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

* In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous(SQ), once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily), demonstrated superior weight loss compared to semaglutide monotherapy (30 nmol/kg, SQ, once daily), show...

2024-12-18 21:43 2191

Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production

SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, announced the grand opening of its state-of-the-art TIL manufacturing facility loc...

2024-12-18 21:08 1260

Apollo Care Secures Growth Equity Investment from Flexpoint Ford to Accelerate Patient Access and Commercial Solutions Initiatives

* Strategic investment from Flexpoint Ford to drive Apollo Care's growth initiatives * Proceeds will be used to expand Apollo Care's innovation pipeline, enhance existing technology, and scale operations  * Flexpoint Ford's Jonathan Oka and Elliot Lauzen join Apollo Care's Board of Director...

2024-12-18 21:00 1403

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)

BEIJING and BRIDGEWATER, N.J., Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) application for GZR18 Injection to conduct ...

2024-12-18 19:34 2359

Tokyo Lifestyle Co., Ltd. Reports First Six Months of Fiscal Year 2025 Financial Results

TOKYO, Dec. 18, 2024 /PRNewswire/ -- Tokyo Lifestyle Co., Ltd. ("Tokyo Lifestyle" or the "Company") (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, as well as other products in Hong Kong, Japan, North Americ...

2024-12-18 19:00 1406

Ayala Corporation partners with ING to secure sustainable finance €50 million, advancing healthcare growth in the Philippines

MANILA, Philippines, Dec. 18, 2024 /PRNewswire/ -- Ayala Corporation signed a €50 million (₱3.1 Billion) social loan from leading European bank ING to support AC Health's portfolio growth.  From left, Wing Bayoneta, Produ...

2024-12-18 17:46 1984

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

BEIJING, Dec. 18, 2024 /PRNewswire/ -- Seoul 120 hotline has contributed to efficient city operation, according to the Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness (2024) released on Wednesday. Photo shows the c...

2024-12-18 16:14 1296

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

- Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development - Investment highlights Samsung's dedication to advancing innovation and creating a robust ecosystem for AI-enabled therapeutic develop...

2024-12-18 13:09 1790

U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

* STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well as adults with Crohn's disease (CD) and ulcerative colitis (UC) * STEQEYMA is a strategic addition to Celltrion's portfolio, expanding the portfolio a...

2024-12-18 11:50 928

Fosun International Awarded TVB's Highest Honor "Outstanding ESG Award"

HONG KONG, Dec. 18, 2024 /PRNewswire/ -- On 13 December 2024, the "TVB ESG Awards" ceremony, hosted by Television Broadcasts Limited (hereinafter referred to as "TVB"), was held at the Hong Kong Convention and Exhibition Centre. Fosun International was honored with the highest accolade, the "Outs...

2024-12-18 11:43 1684

TPIsoftware Expedites Underwriting and Claims Processing for Cathay Life Insurance

TAIPEI, Dec. 18, 2024 /PRNewswire/ -- As a leading expert in Fintech and Insurtech, TPIsoftware has once showcased its digital expertise in delivering tech-driven solutions for Cathay Life Insurance. With Cathay utilizing TPIsoftware's Business Process Management (BPM) platform digiFlexis and dig...

2024-12-18 11:10 1299
1 ... 891011121314 ... 872